The Src Tyrosine Kinase Pathway Regulates Thecal CYP17 Expression and Androstenedione Secretion
Overview
Affiliations
In order to evaluate the role of Src tyrosine kinase in thecal cell steroidogenesis, a pharmacological approach was utilized by treating enriched populations of mouse ovarian theca-interstitial cells in vitro with a direct Src kinase inhibitor, PP2. Inhibition of Src with PP2 increased both basal and forskolin-stimulated androstenedione secretion, and increased cytochrome P450 17-alpha hydroxylase-lyase (CYP17) promoter activity and steady state mRNA. PP2 did not change thecal levels of StAR mRNA. Inhibition of mitogen-activated protein kinase kinase, a downstream regulator of Src activity, using PD98059 also increased forskolin-stimulated secretion of androstenedione above forskolin alone, but had no effect on basal secretion of androstenedione. Src inhibition increased mitogen-activated protein kinase phosphatase-1 protein and decreased phosphorylation of SF-1, which correlated with increased CYP17 promoter activity and mRNA levels. These results implicate Src tyrosine kinase in the regulation of CYP17 and thecal androgen secretion.
Kong L, Wang Q, Jin J, Xiang Z, Chen T, Shen S PLoS One. 2017; 12(11):e0188029.
PMID: 29125859 PMC: 5695281. DOI: 10.1371/journal.pone.0188029.
Liu X, Qiao P, Jiang A, Jiang J, Han H, Wang L Biomed Res Int. 2015; 2015:925691.
PMID: 26357661 PMC: 4556819. DOI: 10.1155/2015/925691.
Wu S, Divall S, Nwaopara A, Radovick S, Wondisford F, Ko C Diabetes. 2014; 63(4):1270-82.
PMID: 24379345 PMC: 3964497. DOI: 10.2337/db13-1514.
Kunal S, Killivalavan A, Medhamurthy R Reprod Biol Endocrinol. 2012; 10:25.
PMID: 22455442 PMC: 3353251. DOI: 10.1186/1477-7827-10-25.